Cargando…
Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network
The lack of standardization in the way that quantitative and systems pharmacology (QSP) models are developed, tested, and documented hinders their reproducibility, reusability, and expansion or reduction to alternative contexts. This in turn undermines the potential impact of QSP in academic, indust...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533407/ https://www.ncbi.nlm.nih.gov/pubmed/30667172 http://dx.doi.org/10.1002/psp4.12381 |
_version_ | 1783421201470717952 |
---|---|
author | Cucurull‐Sanchez, Lourdes Chappell, Michael J. Chelliah, Vijayalakshmi Amy Cheung, S. Y. Derks, Gianne Penney, Mark Phipps, Alex Malik‐Sheriff, Rahuman S. Timmis, Jon Tindall, Marcus J. van der Graaf, Piet H. Vicini, Paolo Yates, James W. T. |
author_facet | Cucurull‐Sanchez, Lourdes Chappell, Michael J. Chelliah, Vijayalakshmi Amy Cheung, S. Y. Derks, Gianne Penney, Mark Phipps, Alex Malik‐Sheriff, Rahuman S. Timmis, Jon Tindall, Marcus J. van der Graaf, Piet H. Vicini, Paolo Yates, James W. T. |
author_sort | Cucurull‐Sanchez, Lourdes |
collection | PubMed |
description | The lack of standardization in the way that quantitative and systems pharmacology (QSP) models are developed, tested, and documented hinders their reproducibility, reusability, and expansion or reduction to alternative contexts. This in turn undermines the potential impact of QSP in academic, industrial, and regulatory frameworks. This article presents a minimum set of recommendations from the UK Quantitative and Systems Pharmacology Network (UK QSP Network) to guide QSP practitioners seeking to maximize their impact, and stakeholders considering the use of QSP models in their environment. |
format | Online Article Text |
id | pubmed-6533407 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-65334072019-05-30 Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network Cucurull‐Sanchez, Lourdes Chappell, Michael J. Chelliah, Vijayalakshmi Amy Cheung, S. Y. Derks, Gianne Penney, Mark Phipps, Alex Malik‐Sheriff, Rahuman S. Timmis, Jon Tindall, Marcus J. van der Graaf, Piet H. Vicini, Paolo Yates, James W. T. CPT Pharmacometrics Syst Pharmacol White Paper The lack of standardization in the way that quantitative and systems pharmacology (QSP) models are developed, tested, and documented hinders their reproducibility, reusability, and expansion or reduction to alternative contexts. This in turn undermines the potential impact of QSP in academic, industrial, and regulatory frameworks. This article presents a minimum set of recommendations from the UK Quantitative and Systems Pharmacology Network (UK QSP Network) to guide QSP practitioners seeking to maximize their impact, and stakeholders considering the use of QSP models in their environment. John Wiley and Sons Inc. 2019-03-22 2019-05 /pmc/articles/PMC6533407/ /pubmed/30667172 http://dx.doi.org/10.1002/psp4.12381 Text en © 2019 The Authors CPT: Pharmacometrics & Systems Pharmacology published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | White Paper Cucurull‐Sanchez, Lourdes Chappell, Michael J. Chelliah, Vijayalakshmi Amy Cheung, S. Y. Derks, Gianne Penney, Mark Phipps, Alex Malik‐Sheriff, Rahuman S. Timmis, Jon Tindall, Marcus J. van der Graaf, Piet H. Vicini, Paolo Yates, James W. T. Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network |
title | Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network |
title_full | Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network |
title_fullStr | Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network |
title_full_unstemmed | Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network |
title_short | Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network |
title_sort | best practices to maximize the use and reuse of quantitative and systems pharmacology models: recommendations from the united kingdom quantitative and systems pharmacology network |
topic | White Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533407/ https://www.ncbi.nlm.nih.gov/pubmed/30667172 http://dx.doi.org/10.1002/psp4.12381 |
work_keys_str_mv | AT cucurullsanchezlourdes bestpracticestomaximizetheuseandreuseofquantitativeandsystemspharmacologymodelsrecommendationsfromtheunitedkingdomquantitativeandsystemspharmacologynetwork AT chappellmichaelj bestpracticestomaximizetheuseandreuseofquantitativeandsystemspharmacologymodelsrecommendationsfromtheunitedkingdomquantitativeandsystemspharmacologynetwork AT chelliahvijayalakshmi bestpracticestomaximizetheuseandreuseofquantitativeandsystemspharmacologymodelsrecommendationsfromtheunitedkingdomquantitativeandsystemspharmacologynetwork AT amycheungsy bestpracticestomaximizetheuseandreuseofquantitativeandsystemspharmacologymodelsrecommendationsfromtheunitedkingdomquantitativeandsystemspharmacologynetwork AT derksgianne bestpracticestomaximizetheuseandreuseofquantitativeandsystemspharmacologymodelsrecommendationsfromtheunitedkingdomquantitativeandsystemspharmacologynetwork AT penneymark bestpracticestomaximizetheuseandreuseofquantitativeandsystemspharmacologymodelsrecommendationsfromtheunitedkingdomquantitativeandsystemspharmacologynetwork AT phippsalex bestpracticestomaximizetheuseandreuseofquantitativeandsystemspharmacologymodelsrecommendationsfromtheunitedkingdomquantitativeandsystemspharmacologynetwork AT maliksheriffrahumans bestpracticestomaximizetheuseandreuseofquantitativeandsystemspharmacologymodelsrecommendationsfromtheunitedkingdomquantitativeandsystemspharmacologynetwork AT timmisjon bestpracticestomaximizetheuseandreuseofquantitativeandsystemspharmacologymodelsrecommendationsfromtheunitedkingdomquantitativeandsystemspharmacologynetwork AT tindallmarcusj bestpracticestomaximizetheuseandreuseofquantitativeandsystemspharmacologymodelsrecommendationsfromtheunitedkingdomquantitativeandsystemspharmacologynetwork AT vandergraafpieth bestpracticestomaximizetheuseandreuseofquantitativeandsystemspharmacologymodelsrecommendationsfromtheunitedkingdomquantitativeandsystemspharmacologynetwork AT vicinipaolo bestpracticestomaximizetheuseandreuseofquantitativeandsystemspharmacologymodelsrecommendationsfromtheunitedkingdomquantitativeandsystemspharmacologynetwork AT yatesjameswt bestpracticestomaximizetheuseandreuseofquantitativeandsystemspharmacologymodelsrecommendationsfromtheunitedkingdomquantitativeandsystemspharmacologynetwork |